Elgene Lim
A/Prof Lim is a clinician scientist, NBCF/VCA Practitioner Fellow and Group Leader of the Translational Breast Cancer Research Laboratory at the Olivia Newton John Cancer Research Institute (ONJCRI). He received his MBBS (Melbourne University) in 1995, FRACP (Royal Australasian College of Physicians) in 2006, and PhD (Melbourne University/WEHI) in 2010, where he characterised the human mammary epithelial cell hierarchy and its relation to breast cancer. At the Dana-Farber Cancer Institute (DFCI) in Boston, he progressed from a clinical fellow (2010), postdoctoral fellow (2011), to Instructor in Medicine at the Harvard Medical School (2012-current). He was recruited in 2014 to start a breast cancer laboratory and lead the translational research in breast cancer at the Olivia Newton-John Cancer & Wellness Centre/Austin Health. His laboratory focuses on steroid hormone receptor signalling, including androgen receptor and resistance to endocrine therapies. He also has a long track record of collaboration with national and internal colleagues, especially in the area of preclinical evaluation of novel therapies and biomarkers in breast cancer, and in establishing and utilizing patient derived xenografts for this purpose.
|